Company Update AUROBINDO PHARMA LTD. - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And … BSE India This is to inform that Curateq Biologicals Private Limited, a wholly owned subsidiary of the Company has entered into an exclusive agreement with the USA based BioFactura Inc, USA to commercialise BFI-751, a proposed biosimilar to Stelara (Ustekinumab).